GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Gross-Profit-to-Asset %

Oxygenta Pharmaceutical (BOM:524636) Gross-Profit-to-Asset % : 32.28% (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Oxygenta Pharmaceutical's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₹204.0 Mil. Oxygenta Pharmaceutical's average Total Assets over the quarter that ended in Mar. 2024 was ₹631.9 Mil. Therefore, Oxygenta Pharmaceutical's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 32.28%.


Oxygenta Pharmaceutical Gross-Profit-to-Asset % Historical Data

The historical data trend for Oxygenta Pharmaceutical's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Gross-Profit-to-Asset % Chart

Oxygenta Pharmaceutical Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.06 37.07 12.16 -9.90 -2.26

Oxygenta Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.54 -22.83 -9.04 -11.71 32.28

Competitive Comparison of Oxygenta Pharmaceutical's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxygenta Pharmaceutical's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's Gross-Profit-to-Asset % falls into.



Oxygenta Pharmaceutical Gross-Profit-to-Asset % Calculation

Oxygenta Pharmaceutical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=-13.248/( (542.647+631.921)/ 2 )
=-13.248/587.284
=-2.26 %

Oxygenta Pharmaceutical's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=203.988/( (0+631.921)/ 1 )
=203.988/631.921
=32.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Oxygenta Pharmaceutical Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxygenta Pharmaceutical (BOM:524636) Business Description

Traded in Other Exchanges
N/A
Address
Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines